Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial.

Authors: Yves Lévy, Christine Lacabaratz, Kim Ellefsen-Lavoie, Wolfgang Stöhr, Jean-Daniel Lelièvre, Pierre-Alexandre Bart, Odile Launay, Jonathan Weber, Bernd Salzberger, Aurélie Wiedemann, Mathieu Surenaud, David M Koelle, Hans Wolf, Ralf Wagner, Véronique Rieux, David C Montefiori, Nicole L Yates, Georgia D Tomaras, Raphael Gottardo, Bryan Mayer, Song Ding, Rodolphe Thiébaut, Sheena McCormack, Geneviève Chêne, Giuseppe Pantaleo

Source: PLoS Pathogens, Vol 16, Iss 6, p e1008522 (2020)

Subject Terms: Immunologic diseases. Allergy, RC581-607, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://doaj.org/toc/1553-7366; https://doaj.org/toc/1553-7374

Access URL: https://doaj.org/article/d2f1645709044450b79a986fab536e92

The human immunodeficiency virus preventive vaccine research at the French National Agency for acquired immunodeficiency syndrome research

Authors: Elizabeth Fischer, Véronique Rieux, Jean-Gérard Guillet, Michel Kazatchkine

Source: Memorias do Instituto Oswaldo Cruz, Vol 100, Iss 1, Pp 79-84 (2005)

Subject Terms: human immunodeficiency virus, vaccine trials, lipopeptides, network, Microbiology, QR1-502, Infectious and parasitic diseases, RC109-216

File Description: electronic resource

Relation: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762005000100015; https://doaj.org/toc/0074-0276; https://doaj.org/toc/1678-8060

Access URL: https://doaj.org/article/5012a7c1e54347f8b808094cff4d5ed6